Technologies for detecting genetic polymorphisms in pharmacogenomics

Molecular Diagnosis

Volumn 4, Issue 4, 1999, Pages 343-351

  Shi, Michael M ^a,b   Bleavins, Michael R ^a,b   de la Iglesia, Felix A ^a,b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Genotyping; Pharmacogenomics; Phenotyping; Polymorphisms

Indexed keywords

ALLELE; DNA SEQUENCE; DRUG RESPONSE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SEQUENCE ANALYSIS;

EID: 0033403326     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-8592(99)80011-3     Document Type: Article

References (2)

1. Kleyn PW, Vesell ES: Genetic variation as a guide to drug development. Science 1998;281:1820-1821
2. Benet LZ, Kroetz DL, Sheiner LB: General principles, In Hardman JG, Limbird LE (eds.): Goodman & Gilman's the pharmacological basis of therapeutics, 9th ed. McGraw-Hill, New York, 1996,3-27